2018
DOI: 10.1007/s00432-018-2612-x
|View full text |Cite
|
Sign up to set email alerts
|

NIPA-like domain containing 1 is a novel tumor-promoting factor in oral squamous cell carcinoma

Abstract: Our findings suggest that NIPAL1 might be a novel factor promoting OSCC tumorigenesis, as well as a useful molecular marker of OSCC.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 32 publications
1
4
0
Order By: Relevance
“…This study detected LEM domain-containing protein 2 in stage 3 breast cancer tissues. This finding is consistent with Sasahira et al [84], however, they evaluated LEM domain-containing protein 2 in the context of oral squamous cell carcinoma tumorigenesis and found that it may be important molecular marker of that cancer [84].…”
Section: Discussionsupporting
confidence: 89%
“…This study detected LEM domain-containing protein 2 in stage 3 breast cancer tissues. This finding is consistent with Sasahira et al [84], however, they evaluated LEM domain-containing protein 2 in the context of oral squamous cell carcinoma tumorigenesis and found that it may be important molecular marker of that cancer [84].…”
Section: Discussionsupporting
confidence: 89%
“…High NIPAL1 expression significantly correlated with cancer cell intravasation and poorer disease-free survival. siRNA-mediated knockdown of NIPAL1 significantly inhibited the growth and adhesion of oral squamous cell carcinoma cells compared with negative siRNA [ 51 ]. These findings indicated that NIPAL2 may also be a tumor-promoting factor in ALL as NIPAL1.…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, NIPAL1 is also associated with gout in a GWAS of more than 4000 Japanese men 45 . Gout is a form of hyperuricemia that can occur in the presence of reduced renal urate excretion, and affected individuals have a 1.18 fold increased risk of developing bladder cancer (95% CI = 1.05–1.32) 46 .…”
Section: Discussionmentioning
confidence: 99%